Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 September 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Positron emission tomography for diagnosis and staging of bile duct cancer

Malignant tumors with high rates of glucose metabolism accumulate [18F]-fluorodeoxyglucose (FDG), a positron-emitting tracer. FDG positron emission tomography (PET) can detect and stage human cholangiocarcinoma (CC) according to research published in May's Hepatology.

News image

fiogf49gjkf04

A team from Germany studied patients with adenocarcinoma of the biliary tree (n = 26), with benign lesions of the bile ducts (n = 8), and 20 control patients who underwent FDG-PET

PET scans for cholangiocarcinoma:
Sensitivity: 92.3%
Specificity: 92.9%
Hepatology

In a blinded fashion, 4 independent experts evaluated the PET scans visually and semi-quantitatively using the standardized uptake value and a tumor/non-tumor ratio.

All adenocarcinomas and benign lesions (sclerosing cholangitis, bile duct adenoma, and Caroli's disease) were histologically proven and imaged by magnetic resonance imaging and endoscopic retrograde cholangioscopy.

The results revealed true-positive PET scans were obtained in 24 of 26 patients with CC and false-negative scans in the other 2 (sensitivity 92%). The PET scan was true-negative in 18 of 20 controls and in all 8 benign biliary lesions (specificity 93%).

Visual and semi-quantitative evaluation using tumor/non-tumor ratios were equally accurate (accuracy 93%), whereas evaluation by standardized uptake value revealed lower accuracy.

Regional or hepato-duodenal lymph node metastases were detected with PET in only 2 of 15 cases. Distant metastases (peritoneal carcinomatosis, pulmonary metastases) were diagnosed in 7 of 10 cases.

Dr Regine Kluge, of University Hospital of Leipzig, Germany, concluded, on behalf of the group, "PET is highly sensitive and specific for the detection and localization of CC.

"It can be helpful for diagnosis of distant metastases but is not suitable for detection of regional lymph node metastases."

Hepatology 2001: 33 (5): 1029-35
11 May 2001

Go to top of page Email this page Email this page to a colleague

 20 September 2017 
Rifaximin and spontaneous bacterial peritonitis in cirrhosis
 20 September 2017 
Omega-3 PUFA and colorectal cancer survival
 20 September 2017 
Beta-blockers and cardiopulmonary exercise testing in liver disease
 19 September 2017 
Birth outcomes in children fathered by men treated with azathioprine
 19 September 2017 
Risk of death and statins in alcoholic cirrhosis
 19 September 2017 
Hospital-readmission risk
 18 September 2017 
Ethnic disparities and Hep C survival
 18 September 2017 
Depression and celiac disease in the USA
 18 September 2017 
Health care services in IBD
 15 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 15 September 2017 
Hemidesmosome integrity and colorectal cancer
 15 September 2017 
Herpes zoster vaccination in IBD
 14 September 2017 
National survey on stopping PPIs
 14 September 2017 
Psychological impact of IBD
 14 September 2017 
Bile tree pathology in patients presenting with gallbladder disease
 13 September 2017 
Predicting clinical outcome in colorectal cancer
 13 September 2017 
Oral contraceptives increases the risk of IBD
 13 September 2017 
Mortality in cirrhosis
 12 September 2017 
Genetic factors and tobacco in IBD
 12 September 2017 
Predictors of colectomy in ulcerative colitis
 12 September 2017 
Low birthweight and pediatric NAFLD
 11 September 2017 
Proteomic analysis of IBD
 11 September 2017 
New therapies to manage Hep B
 11 September 2017 
Ethnic disparities for chronic Hep C survival
 08 September 2017 
Antibiotics and diverticulitis
 08 September 2017 
Improving adherence to colorectal cancer screening
 08 September 2017 
Preoperative workup for colorectal cancer
 07 September 2017 
Nicotine chewing gum after colorectal surgery
 07 September 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 07 September 2017 
Outreach to improve colorectal cancer screening
 06 September 2017 
Novel candidate risk genes for IBD
 06 September 2017 
PPI use and chronic kidney disease
 06 September 2017 
Colorectal cancer surgery in the very elderly patient
 05 September 2017 
Unprovoked Venous Thromboembolism and occult cancer
 05 September 2017 
Hep E seroprevalence and hemodialysis
 05 September 2017 
Antibody tests and detecting celiac disease
 04 September 2017 
Acute pancreatitis and health related quality of life
 04 September 2017 
Infliximab treatment and eHealth in IBD
 04 September 2017 
Contrast-enhanced ultrasound for diagnosis of liver cancer
 01 September 2017 
Late recurrence of Barrett’s esophagus after eradication
 01 September 2017 
Thalidomide ine children with IBD
 01 September 2017 
Occult cancer screening with unprovoked venous thromboembolism
 31 August 2017 
Asthma and IBD development
 31 August 2017 
Environmental factors and IBD
 31 August 2017 
Management of noncardiac chest pain
 30 August 2017 
Diet and increased flares in patients with ulcerative colitis in remission
 30 August 2017 
Induction of remission in pediatric Crohn's disease
 29 August 2017 
Reducing antibody formation against TNF antagonists in IBD
 29 August 2017 
Epidemiological changes of chronic hepatitis
 28 August 2017 
Hyperuricemia and NAFLD activity score
 28 August 2017 
Therapy for acute variceal hemorrhage
 28 August 2017 
Colectomy rates in ulcerative colitis
 25 August 2017 
Making personalized nutrition a reality
 25 August 2017 
Predicting advanced colorectal cancer survival
 24 August 2017 
Bariatric surgery liver biopsies
 24 August 2017 
Guidelines for the management of inherited polyposis syndromes
 24 August 2017 
Steatosis in bariatric surgery candidates with NAFLD
 23 August 2017 
Colectomy rates in patients with ulcerative colitis
 23 August 2017 
Outcomes of bowel cancer screening with a fecal immunochemical test
 23 August 2017 
Arterial stiffness in NAFLD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us